Short Interest in 23andMe Holding Co. (NASDAQ:ME) Rises By 22.3%

23andMe Holding Co. (NASDAQ:ME) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 1,700,000 shares, an increase of 22.3% from the February 13th total of 1,390,000 shares. Based on an average daily volume of 299,500 shares, the short-interest ratio is presently 5.7 days. Approximately 10.7% of the shares of the stock are short sold.

23andMe Price Performance

NASDAQ ME opened at $1.84 on Thursday. 23andMe has a 1-year low of $1.34 and a 1-year high of $12.76. The business has a 50 day simple moving average of $2.64 and a two-hundred day simple moving average of $4.01. The stock has a market capitalization of $49.36 million, a PE ratio of -0.12 and a beta of 1.19.

23andMe (NASDAQ:ME) last announced its quarterly earnings results on Tuesday, January 28th. The company reported ($1.02) earnings per share for the quarter. 23andMe had a negative return on equity of 170.07% and a negative net margin of 183.39%.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of 23andMe in a research note on Friday, March 7th.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of ME. Geode Capital Management LLC boosted its stake in shares of 23andMe by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 4,246,093 shares of the company’s stock worth $1,476,000 after purchasing an additional 28,252 shares during the period. FMR LLC boosted its position in shares of 23andMe by 24.0% during the third quarter. FMR LLC now owns 993,848 shares of the company’s stock valued at $345,000 after buying an additional 192,099 shares during the period. Shay Capital LLC grew its stake in shares of 23andMe by 71.7% during the fourth quarter. Shay Capital LLC now owns 702,530 shares of the company’s stock valued at $2,283,000 after buying an additional 293,358 shares during the last quarter. Virtu Financial LLC bought a new stake in shares of 23andMe during the 4th quarter worth approximately $49,000. Finally, MassMutual Private Wealth & Trust FSB bought a new position in 23andMe in the 4th quarter valued at $40,000. Institutional investors own 36.10% of the company’s stock.

23andMe Company Profile

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.